Sana Biotechnology SANA
NASDAQ SANA
$2.89 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Sana Biotechnology (SANA) Preferred Stock Liabilities (2020)

Updated

Sana Biotechnology (SANA) reported Preferred Stock Liabilities of $852.9 million for Q4 2020, unchanged from the prior quarter.

Analysis

Sana Biotechnology (SANA) Preferred Stock Liabilities (2020) Analysis & Trends

Dating back to Q1 2020, Sana Biotechnology's Preferred Stock Liabilities record includes 4 quarters.

  • By year, Preferred Stock Liabilities came in at $417.36 million in FY2019.
  • Per Business Quant data, the three quarters before Q4 2020 came in at $852.9 million (Q3 2020), $852.9 million (Q2 2020) and $417.36 million (Q1 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Sana Biotechnology 870.98 Mn 870.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 852.90 Mn
Sep 30, 2020 852.90 Mn
Jun 30, 2020 852.90 Mn
Mar 31, 2020 417.36 Mn
API Access

Sana Biotechnology Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=SANA&period=max&api_key=YOUR_API_KEY